| Activity |
| Catalytic type | Metallo |
| Peplist | Included in the Peplist with identifier PL00196 |
| NC-IUBMB | Subclass 3.4 (Peptidases) >> Sub-subclass 3.4.24 (Metalloendopeptidases) >> Peptidase 3.4.24.82
|
| Enzymology | BRENDA database |
| Proteolytic events | CutDB database (53 cleavages) |
| Activity status | human: active (Hughes et al., 2004) mouse: active (by similarity)
|
| Knockout | Mice in which the ADAMTS4 gene was distrupted exhibited no gross or histologic abnormalities, and indicate that, in the mouse, ADAMTS-4 is not the primary enzyme responsible for aggrecan degradation at the TEGE(373-374)ARGS site Glasson et al., 2004. |
| Pharmaceutical relevance | Like ADAM-TS5, ADAM-TS4 is a potential drug target for the treatment of osteoarthritis (Malfait et al., 2002). |
|
Other databases
| WIKIPEDIA | http://en.wikipedia.org/wiki/ADAMTS4 |
| Cleavage site specificity |
Explanations of how to interpret the
following cleavage site sequence logo and specificity matrix can be found here. |
| Cleavage pattern | -/-/-/e a/-/ga/- (based on 506 cleavages) |